7752:TSERicoh Company, Ltd. Analysis
Data as of 2026-03-11 - not real-time
NT$50.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
CHWE is trading well below its short‑ and long‑term moving averages, signaling a pronounced bearish trend, while the RSI indicates the stock is deeply oversold.
Technical momentum is further weakened by a bearish MACD divergence and a price hovering just above a key support zone, with volume picking up despite the downtrend. Fundamentals show modest revenue growth and respectable operating margins, but the balance sheet is strained by high leverage and a valuation that exceeds both the industry average and the company’s own discounted cash‑flow estimate. The combination of high volatility, elevated beta, and a lack of dividend support points to heightened risk, though a strong cash position offers some cushion.
Technical momentum is further weakened by a bearish MACD divergence and a price hovering just above a key support zone, with volume picking up despite the downtrend. Fundamentals show modest revenue growth and respectable operating margins, but the balance sheet is strained by high leverage and a valuation that exceeds both the industry average and the company’s own discounted cash‑flow estimate. The combination of high volatility, elevated beta, and a lack of dividend support points to heightened risk, though a strong cash position offers some cushion.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- price below all major moving averages
- bearish MACD and oversold RSI
- proximity to a near‑term support level
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- modest but positive revenue growth
- solid operating margins offset by high leverage
- valuation gap suggesting potential correction
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- renewable‑energy tailwinds in the utilities sector
- DCF‑derived fair value below current price
- ample cash resources to fund future expansion
Key Metrics & Analysis
Financial Health
Revenue Growth405.00%
Profit Margin16.93%
P/E Ratio24.2
ROE7.27%
ROA3.26%
Debt/Equity44.15
P/B Ratio1.8
Op. Cash FlowNT$969.7M
Free Cash FlowNT$232.9M
Industry P/E20.5
Technical Analysis
TrendBearish
RSI19.3
SupportNT$49.00
ResistanceNT$62.90
MA 20NT$57.46
MA 50NT$62.15
MA 200NT$78.33
MACDBearish
VolumeIncreasing
Fear & Greed Index76.64
Valuation
Fair ValueNT$45.46
GradeOvervalued
TypeValue
Risk Assessment
Beta2.51
Volatility33.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.